Resolution of macular edema in Coats' disease with intravitreal bevacizumab

A 13-year-old boy was referred because of visual deterioration in his right eye. The visual acuity was two meters of counting fingers. Indirect ophthalmoscopy and biomicroscopy revealed exudative macular edema as well as tumor-like telangiectatic vessels and exudation in temporal periphery. With dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Entezari, Morteza, Ramezani, Alireza, Safavizadeh, Ladan, Bassirnia, Nader
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841384/
https://www.ncbi.nlm.nih.gov/pubmed/20029156
http://dx.doi.org/10.4103/0301-4738.58482
_version_ 1782179111661207552
author Entezari, Morteza
Ramezani, Alireza
Safavizadeh, Ladan
Bassirnia, Nader
author_facet Entezari, Morteza
Ramezani, Alireza
Safavizadeh, Ladan
Bassirnia, Nader
author_sort Entezari, Morteza
collection PubMed
description A 13-year-old boy was referred because of visual deterioration in his right eye. The visual acuity was two meters of counting fingers. Indirect ophthalmoscopy and biomicroscopy revealed exudative macular edema as well as tumor-like telangiectatic vessels and exudation in temporal periphery. With diagnosis of Coats' disease (stage II) confirmed by fluorescein angiography, three intravitreal injections of bevacizumab were performed at 6-week intervals. One year after the last injection, there was a significant resolution of macular edema as well as visual acuity improvement to 20/20. This is the first case report in which a distinct improvement in macular edema was observed with intravitreal bevacizumab in Coats' disease.
format Text
id pubmed-2841384
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-28413842010-03-24 Resolution of macular edema in Coats' disease with intravitreal bevacizumab Entezari, Morteza Ramezani, Alireza Safavizadeh, Ladan Bassirnia, Nader Indian J Ophthalmol Brief Communications A 13-year-old boy was referred because of visual deterioration in his right eye. The visual acuity was two meters of counting fingers. Indirect ophthalmoscopy and biomicroscopy revealed exudative macular edema as well as tumor-like telangiectatic vessels and exudation in temporal periphery. With diagnosis of Coats' disease (stage II) confirmed by fluorescein angiography, three intravitreal injections of bevacizumab were performed at 6-week intervals. One year after the last injection, there was a significant resolution of macular edema as well as visual acuity improvement to 20/20. This is the first case report in which a distinct improvement in macular edema was observed with intravitreal bevacizumab in Coats' disease. Medknow Publications 2010 /pmc/articles/PMC2841384/ /pubmed/20029156 http://dx.doi.org/10.4103/0301-4738.58482 Text en © Indian Journal of Ophthalmology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Communications
Entezari, Morteza
Ramezani, Alireza
Safavizadeh, Ladan
Bassirnia, Nader
Resolution of macular edema in Coats' disease with intravitreal bevacizumab
title Resolution of macular edema in Coats' disease with intravitreal bevacizumab
title_full Resolution of macular edema in Coats' disease with intravitreal bevacizumab
title_fullStr Resolution of macular edema in Coats' disease with intravitreal bevacizumab
title_full_unstemmed Resolution of macular edema in Coats' disease with intravitreal bevacizumab
title_short Resolution of macular edema in Coats' disease with intravitreal bevacizumab
title_sort resolution of macular edema in coats' disease with intravitreal bevacizumab
topic Brief Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841384/
https://www.ncbi.nlm.nih.gov/pubmed/20029156
http://dx.doi.org/10.4103/0301-4738.58482
work_keys_str_mv AT entezarimorteza resolutionofmacularedemaincoatsdiseasewithintravitrealbevacizumab
AT ramezanialireza resolutionofmacularedemaincoatsdiseasewithintravitrealbevacizumab
AT safavizadehladan resolutionofmacularedemaincoatsdiseasewithintravitrealbevacizumab
AT bassirnianader resolutionofmacularedemaincoatsdiseasewithintravitrealbevacizumab

Ejemplares similares